z-logo
open-access-imgOpen Access
WHY DO PRESCRIPTION DRUG PRICES INCREASE? STATE MEDICAID EXPANSION, EXECUTIVE COMPENSATION AND CORPORATE GOVERNANCE
Author(s) -
Mosab Hammoudeh,
Amrita Nain Nain,
Tarek Zaher Zaher
Publication year - 2022
Publication title -
international journal of finance
Language(s) - English
Resource type - Journals
ISSN - 2520-0852
DOI - 10.47941/ijf.984
Subject(s) - corporate governance , executive compensation , business , prescription drug , stock (firearms) , shock (circulatory) , accounting , medical prescription , economics , finance , medicine , mechanical engineering , engineering , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here